Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Verkazia (cyclosporine)

Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

Call For Patient Input: April 23, 2019

Patient Input Closed: June 12, 2019

Cuvposa (glycopyrrolate )

Indications: chronic severe drooling, neurologic (pediatric)

Call For Patient Input: April 11, 2019

Patient Input Closed: June 3, 2019

Lokelma (sodium zirconium cyclosilicate)

Indications: Hyperkalemia, adults

Call For Patient Input: April 4, 2019

Patient Input Closed: May 27, 2019

Aimovig (erenumab )

Indications: Migraine

Call For Patient Input: April 4, 2019

Patient Input Closed: May 27, 2019

Trintellix (vortioxetine hydrobromide)

Indications: Major depressive disorder (MDD), adults.

Call For Patient Input: April 2, 2019

Patient Input Closed: May 23, 2019

Fibristal (ulipristal acetate)

Indications: Uterine fibroids (signs and symptoms)

Call For Patient Input: March 29, 2019

Patient Input Closed: May 21, 2019

Contrave (naltrexone hydrochloride and bupropion hydrochloride)

Indications: Chronic weight management in adults

Call For Patient Input: March 28, 2019

Patient Input Closed: May 17, 2019

Iluvien (fluocinolone acetonide intravitreal implant)

Indications: diabetic macular edema

Call For Patient Input: March 6, 2019

Patient Input Closed: April 25, 2019

Translarna (ataluren)

Indications: Dystrophinopathy

Call For Patient Input: March 5, 2019

Patient Input Closed: April 24, 2019

Revestive (teduglutide )

Indications: Short Bowel Syndrome (SBS), pediatrics

Call For Patient Input: March 4, 2019

Patient Input Closed: April 23, 2019